title: Natural variations at position 93 of the invariant Vα24-Jα18 α chain of human iNKT-cell TCRs strongly impact on CD1d binding.
abstract: Human invariant natural killer T (NKT) cell TCRs bind to CD1d via an "invariant" Vα24-Jα18 chain (iNKTα) paired to semi-invariant Vβ11 chains (iNKTβ). Single-amino acid variations at position 93 (p93) of iNKTα, immediately upstream of the "invariant" CDR3α region, have been reported in a substantial proportion of human iNKT-cell clones (4-30%). Although p93, a serine in most human iNKT-cell TCRs, makes no contact with CD1d, it could affect CD1d binding by altering the conformation of the crucial CDR3α loop. By generating recombinant refolded iNKT-cell TCRs, we show that natural single-nucleotide variations in iNKTα, translating to serine, threonine, asparagine or isoleucine at p93, exert a powerful effect on CD1d binding, with up to 28-fold differences in affinity between these variants. This effect was observed with CD1d loaded with either the artificial α-galactosylceramide antigens KRN7000 or OCH, or the endogenous glycolipid β-galactosylceramide, and its importance for autoreactive recognition of endogenous lipids was demonstrated by the binding of variant iNKT-cell TCR tetramers to cell surface expressed CD1d. The serine-containing variant showed the strongest CD1d binding, offering an explanation for its predominance in vivo. Complementary molecular dynamics modeling studies were consistent with an impact of p93 on the conformation of the CDR3α loop.
authors.affiliation: Academic Unit of Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
authors.forename: Joseph P
authors.initials: JP
authors.lastname: Sanderson
authors.forename: Kathrin
authors.initials: K
authors.lastname: Waldburger-Hauri
authors.forename: Diana
authors.initials: D
authors.lastname: Garzón
authors.forename: Gediminas
authors.initials: G
authors.lastname: Matulis
authors.forename: Salah
authors.initials: S
authors.lastname: Mansour
authors.forename: Nicholas J
authors.initials: NJ
authors.lastname: Pumphrey
authors.forename: Nikolai
authors.initials: N
authors.lastname: Lissin
authors.forename: Peter M
authors.initials: PM
authors.lastname: Villiger
authors.forename: Bent
authors.initials: B
authors.lastname: Jakobsen
authors.forename: José D
authors.initials: JD
authors.lastname: Faraldo-Gómez
authors.forename: Stephan D
authors.initials: SD
authors.lastname: Gadola
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology; D055610:Antigens, CD1d / Q000235:genetics / Q000276:immunology*; D005434:Flow Cytometry; D005699:Galactosylceramides / Q000494:pharmacology; D014644:Genetic Variation; D006801:Humans; D007144:Immunoglobulin J-Chains / Q000235:genetics / Q000276:immunology*; D007135:Immunoglobulin Variable Region / Q000235:genetics / Q000276:immunology*; D007963:Leukocytes, Mononuclear / Q000276:immunology; D056004:Molecular Dynamics Simulation; D055611:Natural Killer T-Cells / Q000276:immunology*; D011485:Protein Binding; D011948:Receptors, Antigen, T-Cell / Q000235:genetics / Q000276:immunology*; D020349:Surface Plasmon Resonance
chemical_list: D000276:Adjuvants, Immunologic; D055610:Antigens, CD1d; D005699:Galactosylceramides; D007144:Immunoglobulin J-Chains; D007135:Immunoglobulin Variable Region; D011948:Receptors, Antigen, T-Cell; C103873:KRN 7000